The global non-animal softgel capsules market size USD 360.2 million in 2020 and expected to reach USD 525.8 million by 2027, at a CAGR of 5.5% during forecast period 2021-2027. Gelatin is used as major raw material while making Softgel capsules. There is an increasing demand for natural and green products from health conscious customers hence driving the market growth and bringing more opportunities in for the players. Moreover, rise in awareness about the health among the population, increase in the demand for non-animal softgel capsules due to surge in vegan population and religious myths, wide range of advantages with softgel capsules such as compatibility with high temperature, and launch of newer products are anticipated to propel the non-animal softgel capsules market over the forecast years. However, Fluctuations in raw material prices, adoption of alternate nutritional products such as powders and injections, and complications in the manufacturing process are anticipated to restrain the growth of market in the near future. Adoption of nutritional supplements due to wide benefits with the products is a key factor surge the growth of global non-animal softgel capsules market over the forecast years. Softgel capsules are easily absorb and may enhance the bioavailability of the products. Rapid growth in global population demanding for vegan products may generate the revenue of market. Currently, approximately 45% capsules are made up of pork meat and bones and only 3% of the global softgel capsules production is from halal or permissible ingredients which is a major concern for the Muslim population may leads to surge in the adoption of vegan softgel capsules over the forecast period.